In a retrospective, longitudinal case–control study of 886 BRCA1/2 mutation carriers, Lammert et al. (2018) showed that women moderately active between the ages of 12–17 years had a 38% lower risk of developing premenopausal breast cancer compared to less active women10. The gene discussed is BRCA1; the disease is breast cancer.